We previously described in piglets after heterotopic cardiac transplantation the early development of a coronary arteriopathy characterized by increased immunostaining for fibronectin and interleukin-1,6 (IL-1,6) in the vessel wall. The objective of this study was to culture smooth muscle cells from donor and host coronary arteries in these piglets to determine whether donor cells produce more fibronectin than host cells as judged by increased protein and mRNA levels, and whether IL-1fi may be regulating this increase by an autocrine mechanism involving increased production of the cytokine. We documented increased donor coronary artery smooth muscle cell fibronectin protein synthesis and mRNA compared to host. By using neutralizing antibodies to IL-lfl, fibronectin protein synthesis and mRNA levels were reduced in donor cells to the levels observed in the host cells and a similar reduction in synthesis was observed with the IL-I receptor antagonist. Immunoprecipitation of newly synthesized IL-1# revealed increased endogenous levels in donor compared to host cells. We therefore suggest in the coronary arteriopathy a pathophysiologic mechanism whereby IL-1,6-mediated increased fibronectin synthesis may promote lymphocyte trapping and migration of medial smooth muscle cells leading to progressive intimal thickening associated with the post-cardiac transplant coronary arteriopathy. (J. Clin.
Introduction
The development of an obstructive coronary arteriopathy is a major cause of morbidity and mortality in cardiac transplant recipients ( 1, 2) accounting for 36% of the deaths in patients who survive beyond 1 yr after transplantation (3) . The most widely accepted current thinking regarding the pathogenesis of the post-cardiac transplant coronary arteriopathy (PCTCA)' is that there is an ongoing immune-inflammatory reaction in the vessel wall with activation of endothelial cells expressing major histocompatibility complex (MHC) II antigens which stimulate lymphocyte proliferation and sustained release ofcytokines. This could cause proliferation and migration of smooth muscle cells into the subendothelium and accumulation of extracellular matrix contributing to intimal thickening (4) .
Others have shown an association between fibronectin (5, 6) and glycosaminoglycan (GAG) (7) accumulation and intimal proliferation in atherosclerosis. Our previous studies addressing the mechanisms involved in the intimal proliferation that occurs in the ductus arteriosus have related increased smooth muscle cell fibronectin synthesis and increased endothelial cell hyaluronan synthesis to enhanced smooth muscle cell migration (8) . Fibronectin is also involved in promoting adhesion of inflammatory cells to endothelial cells, transendothelial migration, and the positioning of these cells in the subendothelium (9-1 1 ), features associated with the immuneinflammatory reaction observed in the pathogenesis of graft atherosclerosis.
An increase in circulating levels and in tissue expression of cytokines after organ transplantation has been reported ( 12, 13) . Although increased expression of IL-1 has not been described specifically in association with the PCTCA, it has been demonstrated experimentally in a murine cardiac allograft ( 14) . Increased expression of IL-1 mRNA and protein has been found in the nonhuman atherosclerotic plaque ( 15) , and, because of its numerous biological functions, this cytokine may play an important role in vascular pathology. For example, IL-I regulates smooth muscle cell proliferation, stimulates leukocyte adherence to the endothelium, and induces GAG synthesis by fibroblasts (16) (17) (18) . Also, it has been shown that smooth muscle cells, once induced by exogenous IL-1 or IL-6, maintain endogenous upregulation ofthese cytokines ( 19, 20) . TGF-3 is also an important modulator of the extracellular matrix, e.g., it increases fibronectin synthesis in different cell types (21, 22) . Our previous studies have shown that the increase in GAG synthesis by endothelial cells detected in the ductus arteriosus associated with intimal thickening is TGF-f dependent (23) . A relationship between inflammatory cells, cytokines, and an increase in matrix proteins contributing to intimal thickening has been demonstrated by Navab et al. (24) . When aortic endothelial and smooth muscle cells were co-cultured with monocytes, increased fibronectin synthesis was observed and found to be partially dependent on IL-I and IL-6 (24) .
Although several animal species have been used to investigate the pathogenesis of PCTCA, there are distinct advantages in using piglets as an experimental model. The piglet most closely resembles the human in the development ofatherosclerosis not induced by a high cholesterol diet (25) , and the size and morphology of the arteries allow the harvesting ofcells for in vitro experiments to address mechanisms involved in the pathogenesis of the PCTCA. Moreover, the pattern of allograft rejection involving MHC mismatching observed in humans is virtually identical to that in piglets (26, 27) .
We previously described changes related to the development of the PCTCA in piglets after heterotopic cardiac transplantation. We demonstrated the presence of an immune-inflammatory reaction in the donor heart coronary arteries characterized by the infiltration of T cell subsets (CD4', CD8', and CD2+), granulocytes, and monocytes, in addition to the expression of MHC II molecules in the endothelium. We found a significant increase in accumulation of fibronectin in the donor coronary arteries associated with increased expression of IL-13. These findings did not appear to be related to the use of cyclosporine A (CsA), the duration ofthe experimental period, or the rejection grade (28) . We speculated that the increased fibronectin accumulation was related to increased synthesis by vascular cells and was regulated by IL-1/ in a paracrine or autocrine manner.
In this study we cultured smooth muscle cells from donor and host coronary arteries from piglets after heterotopic cardiac transplantation, characterized these cells according to their production of extracellular matrix, and were able for the first time to address specifically whether they maintained an altered phenotype associated with increased fibronectin synthesis and whether this abnormality was regulated by increased endogenous production ofIL-1 / or other cytokines, e.g., TGF-/, IL-1 a, and IL-6. We in fact documented increased fibronectin synthesis in smooth muscle cells from donor coronary arteries compared to host associated with increased mRNA levels for fibronectin. We were able to neutralize the increase in donor coronary artery fibronectin synthesis, but only with antibodies to IL-1/3 or the IL-1 receptor antagonist. We further showed increased IL-1/ synthesis by donor coronary artery smooth muscle cells. These in vitro observations are supported by our in vivo findings and suggest a mechanism whereby increased IL-1 /3 upregulates smooth muscle cell fibronectin production by an autocrine mechanism. Increased fibronectin could contribute to transendothelial inflammatory cell migration and trapping in the subendothelium, as well as migration of smooth muscle cells from the media into the subendothehum, features observed in the pathophysiology of the PCTCA.
Methods

Experimental animal preparation
Outbred piglets between 8 and 12 wk of age weighing [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] kg underwent a heterotopic cardiac allograft. This involved retroperitoneal anastomoses ofthe donor ascending aorta and main pulmonary artery with the recipient abdominal aorta and inferior vena cava, respectively, keeping the native heart in the original position. This procedure required removal ofone kidney to graft the donor heart in the retroperitoneal space. Further technical details ofthe surgery have previously been described (29) . The animals were unselected to favor an HLA mismatch and both host and donor animals were purchased from different sources. Each donor heart received crystalloid cardioplegia before transplantation and the donor hearts were grafted within 15 min of cardioplegic arrest. The cardioplegic solution consisted of 5% dextrose with 1.6 mM Mg S04, 0.54 mM tris (hydroxymethyl) amino methane, 29 mM NaCl, and 21.4 mM KCI at pH 8.14 and osmolarity 351. The animals received penicillin G ( 150,000 U i.m.) and standard postoperative care in compliance with the Principles of Laboratory Animal Care formulated by the Canadian National Society of Medical Research. The experimental protocol was approved by the Animal Care Committee of The Hospital for Sick Children, Toronto.
A total of 14 piglets were studied: 7 were treated with a subtherapeutic regimen of CsA (Sandimune, Sandoz, East Hanover, NJ) (10 mg/kg per d for 5 d) and the remaining 7 piglets received no immunosuppressive therapy. All piglets had electrocardiographic monitoring performed daily by telemetric assessment (Pacesetter System, Inc., Syalam, CA) to identify signs of progressive rejection as previously described (30) . A decrease of 30% compared to baseline in the electrocardiographic voltage by 4 d and of 50% thereafter was the indication used to terminate the experiments. These indications were a reflection of myocardial rejection grades II and III. Based on these criteria, 7 CsA-treated piglets were followed for an experimental period of 4-31 d (median 10 d) and the 7 non-CsA-treated piglets were followed for an experimental period of only 4-8 d (median 4 d).
Harvest of coronary artery tissue and propagation of smooth muscle cells Coronary artery segments, -1 cm from the origin at the aorta and 4 cm in length, were removed from both the host and the donor hearts and rinsed in Dulbecco's PBS with 3% antibiotics/antimycotics (Gibco, Burlington, ON). The most distal I cm of these segments was fixed for light and electron microscopy (0.5 cm, respectively) to analyze structural changes previously described (28) . The proximal 3 cm of coronary artery was used for harvest and culture of cells.
After removing the endothelium, explants from the media were used to propagate the smooth muscle cells (31 ) used in the present studies. The cells were cultivated in medium 199 with 25 mM Hepes buffer, glutamine, and 1% antibiotics/antimycotics (Gibco) and 10% FBS (Intergen, New York). Cells were passaged 1:2 nonenzymatically into 25-ml flasks and all experiments were carried out using cells at passages 2 and 3 . The number of harvests (piglets) studied and the number of determinations made (flasks) are given in Results and in the figure legends.
Characterization ofthe in vitro system
Identification ofcells. Only cells with the "hills and valleys" phenotype on phase contrast light microscopy (Nikon Diaphot, Nikon, Mississauga, ON) were considered smooth muscle cells and were further positively identified by immunofluorescence using monoclonal antibodies specific to smooth muscle actin (Enzo, New York) (32). Virtually all cells stained positively as we have previously shown (33). added for 24 h. We did not use methionine-free medium, as in our previous studies (23) . Smooth muscle cells from host and donor coronary arteries were always assayed at the same time.
PREPARATION OF MEDIUM, CELL LAYERS, AND MATRICES
The culture medium was removed and saved in the presence of protease inhibitors (2 mM PMSF (Eastman Kodak Co., Rochester, NY), 10 mM N-ethylmaleamide, and 10 mM EDTA (Sigma). The cell layers were extracted with hypotonic buffer followed by rinsing in 0.5% NP-40 (Sigma) (35) , and the matrices remaining in the flasks were removed after an overnight incubation at 4VC with 2 M guanidine (Sigma). The cell lysates and matrices were stored at -70'C.
ANALYSIS OF GAGs
Soluble GAG fractions from smooth muscle culture medium, were precipitated according to the method used by Copp and Bernfield (36) and the final GAG precipitates were resuspended in water. The final separation of hyaluronan, heparan sulfate, and chondroitin sulfate was performed using an HPLC system (Waters, Milford, MA) with a TSK 3SW DEAE column ( 15 X 15, Beckman Instruments, Inc., Palo Alto, CA) with a three-step NaCl gradient from 0.05 to 0.75 M (37) . Fractions were collected every 2 min and radioactivity was determined by liquid scintillation spectrometry. Individual peaks were confirmed by their susceptibility to heparinitase (Sigma), chondroitinase ABC (Sigma), and streptomyces hyaluronidase (Calbiochem Corp., La Jolla, CA).
EXTRACTION OF FIBRONECTIN
To extract fibronectin, 400-il aliquots of medium and cells were applied to a Gelatin 4B-Sepharose (Pharmacia, Uppsala, Sweden) microcolumn (38) . The fibronectin retained was eluted by boiling the samples for 3 min in 200 1l of SDS sample buffer and resolved on 5% SDS-PAGE under reducing conditions. The gels were prepared for autoradiography for quantitative analysis by treatment with En3Hance
(DuPont-New England Nuclear) for 2 h and dried on a model 443 slab dryer (Bio-Rad Laboratories, Richmond, CA) and exposed to Kodak X-OMAT AR-5 film for 3 d at -70°C. Using the autoradiograph as a template, the doublet 220 kD band corresponding to fibronectin was cut and radioactivity was determined by liquid scintillation spectrometry. Positive determination of this band as fibronectin was confirmed by Western immunoblot. Screeningfor candidate cytokines that regulate fibronectin synthesis. In confluent smooth muscle cells from the host and donor coronary arteries, the medium was replaced by serum-free medium (2 ml), and the cells were labeled with [35S]methionine (10 ,uCi/ml) and incubated at 37°C for 24 h with neutralizing antibodies, i.e., rabbit anti-TGF-, from porcine platelets (AB-1O-NA, R & D Systems, Minneapolis, MN) ( 10 Al/ml) or rabbit anti-porcine IL-la , or IL-lB (a gift from Dr. Saklatvala, Strangeways Laboratory, Cambridge, England and used in a 1:10,000 and 1:50 dilution, respectively), and rabbit anti-human IL-6 (Genzyme, Boston, MA) used in a 1:50 dilution (20 ,g/ml).
All the experiments were controlled by using rabbit IgG (Dako Corp., Santa Barbara, CA) in similar concentration to that of the antibody used. Fibronectin and total protein synthesis were measured as described above. Chomczynski and Sacchi (40) . A purified 1.5-kb human fibronectin cDNA purchased from Telios Pharmaceuticals (La Jolla, CA) was labeled with [32PJdCTP using a random primer kit (Amersham) and probes with specific activities of > 109 cpm/gg were recovered after Sephadex G-50 column chromatography. Prehybridizations and hybridizations were performed for 24 h at 420C using standard techniques. The stringency conditions for washing involved alternating 2 x SSC with 0.1 SSC with 0.1% SDS added to both, at 50'C from a total of 2.5 h. Stock SSC (20X) is made up by adding NaCl 701 g to Na citrate 352 g in 4 liters of diethyl pyrocarbonate water. Autoradiographs ofRNA blot hybridizations were analyzed by quantitative densitometry (Bio-Rad model 620) of appropriately exposed film (Kodak X-OMAT AR5). Values were standardized by densitometry to mRNA levels of a "housekeeping" gene, glyceraldehyde-3-phosphate dehydrogenase (GAPD), and also to 1 8s and 28s ribosomal RNA assessed from the ethidium bromide stained gels to correct for any differences in total RNA loaded onto the gels. A 1.2-kb cDNA probe for GAPD was purchased from ATCC (Rockville, MD) and isolated from pBR322 by Pst 1 digestion. We also measured fibronectin mRNA levels after incubation of smooth muscle cells with neutralizing IL-1,B antisera (dilution 1:50). For these experiments, fibronectin mRNA levels were determined at 12 h after a preliminary time-course assessment which indicated that this was a reliable time point. Rabbit IgG was used as a control.
Immunoprecipitation of newly synthesized IL-1,B by smooth muscle cells Measurement of IL-1f synthesized by both host and donor coronary artery smooth muscle cells was performed by immunoprecipitation after incubation of confluent cells with 100 ,Ci/ml [35S]methionine for 24 h in serum-free medium. Medium was saved with protease inhibitors and cells were lysed using lx lysis buffer (50 mM Tris-Cl pH 7.5, 150 mM NaCl, 1% NP-40 [Sigma], 0.5% sodium deoxycholate [Sigma], 0.1% SDS). Aliquots of 1 ml of cell lysates were then incubated with nonimmune rabbit IgG (0.05 volumes) (Dako Corp.) for 4 h at 4°C followed by clearing with 100 Ml of Protein A agarose (Sigma) for 1 h. The samples were centrifuged at 10,000 g for 5 min and the supernatant incubated with anti-IL-lfI antibodies in a 1:100 dilution for 24 h at 4°C. Another 100 ,ul of Protein A agarose was added for 1 h. The samples were then washed four times with RIPA buffer and the final pellet was resuspended in 50 ,l of SDS sample buffer and heated for 10 min before loading in a 12.5% SDS-PAGE. The gels were prepared for autoradiography as described above. Bands appearing at -30 kD corresponding to the precursors of IL-1fI were cut and analyzed by liquid scintillation spectrometry as described above. Results were expressed as cpm/ 100 ng DNA.
Statistical analysis
Data are expressed as mean±SE in Results and in the figure legends. In analyses related to cell growth, protein, and GAG synthesis, the Student t test was used to compare host and donor cells. We also used the Student t test to determine whether there was an increase in fibronectin synthesis in response to higher doses of IL-1,B when compared with control values and lower doses. Since not all harvests showed a greater than twofold increase in donor versus host fibronectin synthesis, we used the Fisher's exact test to assess whether this variability might be related to the duration of transplant in the CsA-treated and non-CsAtreated piglets. In all analyses a P < 0.05 was considered significant. In all other experiments, values in the donor are expressed as a percentage of those in the host.
Results
Growth and protein synthesis. We first determined whether there were differences between donor and host coronary artery smooth muscle cells related to growth. Comparing host and donor coronary artery smooth muscle cells harvested from three different piglets-one non-CsA-treated at 7 d after cardiac transplantation and two CsA-treated piglets at 7 and 8 d after transplantation, we observed no significant differences in the rate of growth (Fig. 1 ) or protein synthesis. The latter was assessed by measuring methionine-labeled proteins recovered in the cell culture medium (host values 7,727 cpm/ 100 ng DNA±3,186 SE; donor values 8,653 cpm/ 100 ngDNA±4,156 SE).
Synthesis of GAGs. Production of extracellular matrix GAGs in host and donor coronary artery smooth muscle cells from the above harvests were not significantly different with respect to synthesis of hyaluronan, heparan sulfate, or chondroitin sulfate (Fig. 2) . The increase in donor coronary artery smooth muscle cell heparan sulfate was not statistically significant (P = 0.144), and is based upon a high donor value in only one the three animals studied.
Synthesis offibronectin. There was, however, an increase in donor smooth muscle cell fibronectin synthesis compared to that of host in these initial harvests. We therefore extended our analyses to include cells from 14 different piglets: 7 non-CsAtreated piglets at 4-8 d after cardiac transplantation and 7 CsAtreated piglets at 7-31 d after transplantation. In five of seven harvests obtained from non-CsA-treated piglets at 4 d or CsAtreated animals at 7-8 d after cardiac transplantation, there was either no or only a modest (< 150%) increase in fibronectin synthesis in donor compared to host coronary artery smooth muscle cells, whereas in six of seven harvests from non-CsA-treated piglets at 7-8 d or CsA-treated piglets at 10-31 d after cardiac transplantation, a 200-800% increase in fibronectin synthesis was observed (P < 0.05) (Fig. 3) . These data suggest that the increase in fibronectin synthesis is expressed earlier in cultured donor coronary artery smooth muscle cells from non-CsA-treated animals. They also may suggest that a certain duration of expression in vivo is required before the cultured cells will maintain this property in vitro. There was no significant difference (P = 0.27) in relative values comparing the two groups with higher donor fibronectin synthesis, i.e., the non-CsA group at 7-8 d after cardiac transplantation and the CsA treated group at 10-31 d. Fig. 4 shows a representative Northern blot.
Identification ofthe cytokine regulating the increasedfibronectin synthesis. We next carried out screening studies to determine whether cytokines known to be involved in the regulation of fibronectin synthesis and important in the immune-inflammatory reaction in allograft transplantation may be mediating the response observed. In these and all subsequent experiments, only cell harvests showing an increase in donor compared to host fibronectin synthesis were studied. The concentration of TGF-f3 antibody used was based on the doses which neutralized 80% of [3H ]thymidine incorporation in lung epithelial cells (R & D Systems) and also neutralized increased extracellular matrix production by endothelial cells in other studies carried out in our laboratory (23) . The concentrations used of IL-la and IL-1,8 gave 90% inhibition of 1.2 ng/ml porcine IL-la and 84% inhibition of 2.5 ng/ml porcine IL-1I3-induced proliferation of chondrocytes and fibroblasts (41) . The concentration used of IL-6 antibody was in excess of the dilution used to block increased fibronectin synthesis by aortic endothelial and smooth muscle cells induced in co-culture experiments with monocytes (24) .
In host coronary artery smooth muscle cells studied from three or four different harvests, we found no significant differences in fibronectin synthesis in the presence of neutralizing antibodies to TGF-fl, IL-1 a, IL-6, or IL-13 (Fig. 5 A) . This was also the case in the donor coronary artery smooth muscle cells in experiments with TGF-3, IL-1 a, and IL-6 (Fig. 5 B) , but not with IL-I1p. The use of the neutralizing antibody to IL-1( consistently reduced donor coronary artery smooth muscle cell fibronectin synthesis even when we extended these analyses to include cells from eight different piglets (mean 58±4% SE). Fibronectin synthesis in host compared to donor coronary artery smooth muscle cells in the same group of piglets showed a similar 56±12% SE reduction. This suggested that endogenous IL-13 could account for the increased fibronectin synthesis in donor relative to host cells. The decrease in fibronectin synthesis in donor cells in the presence of IL-I( neutralizing antibodies was not associated with a generalized decrease in protein synthesis. In fact, in the donor coronary artery smooth muscle cells from six piglets assessed, values for total protein synthesis recovered in the cell culture medium in the presence of IL-13 antibodies were 175±12.4% SE of those in untreated cells. Experiments with the IL-I receptor antagonist. To further establish that IL-1( might be mediating the increase in donor coronary artery smooth muscle cell fibronectin synthesis, we repeated the above experiments using the IL-1 receptor antagonist (ra) from R & D Systems in cells from three different harvests. Cultured smooth muscle cells were incubated for 24 h with IL-l ra in a dose range of 1-100 ng/ml and fibronectin was extracted as described above. We also measured total proteins synthesized and secreted in the cultured medium (as described above) to assess whether changes in fibronectin were related to changes in total protein synthesis. Normal rabbit IgG was used as a control.
With increasing doses of the IL-ra, we observed a progressive reduction in donor coronary artery smooth muscle cell fibronectin synthesis. reduced by the IL-1 ra. The reduction in donor coronary artery smooth muscle cell fibronectin synthesis in the presence of the IL-I ra was not associated with a reduction in total protein synthesis as judged by values in two different experiments which ranged from 82% to 121% at 10 ng/ml and from 170% to 194% at 20 ng/ml of those in untreated cells.
Addition of Exogenous IL-J,8. To confirm that coronary artery smooth muscle cells can respond to IL-1( by an increase in fibronectin synthesis, increasing doses of human recombinant IL-1(3 from 0.1 to 100 ng/ ml (a gift from Dr. Nigel Staite, The Upjohn Co., Kalamazoo, MI) were added to the host cells in serum-free medium. The results were consistent in cells from all three different piglets studied, showing an increase in fibronectin synthesis in the presence of exogenous IL-1(3, at a concentration between 0.5 and of 20 ng/ml (P < 0.02) (Fig. 7) .
IL-I: andfibronectin mRNA levels. Because the increase in donor compared to host fibronectin synthesis was accompanied by an increase in mRNA levels for fibronectin, we assessed whether the effect of the neutralizing IL-1( antibody was to reduce fibronectin mRNA as well as protein. In the cells from three different piglets assessed that we observed by relative densitometry, mRNA values in the IL-1( antibody-treated samples were reduced by 43±3.3% SE (range 36-47%) compared to control samples treated with rabbit IgG, as judged by using GAPD as the housekeeping gene, and by 41±18% SE (range 22-77%) normalizing by ribosomal RNA, and this correlated with the reduction in protein synthesis observed. Fig. 8 shows a representative Northern blot.
IL-J( synthesis. Once we documented that endogenous IL-1(3 upregulates fibronectin synthesis in donor smooth muscle cells, we determined whether IL-1(3 synthesis was increased in these cells. In observed, we immunoprecipitated newly synthesized IL-If.
We confirmed that donor coronary artery smooth muscle cells produce more IL-113 than host cells (mean 150%, range 125-208%).
Discussion
In this study, we cultured donor and host coronary artery smooth muscle cells from piglets after heterotopic cardiac transplantation and found that there was an increase in fibronectin synthesis in the majority of donor cultures, especially with increasing duration after the cardiac transplant. Moreover, the increase in fibronectin synthesis appeared to be regulated by increased production of IL-1p. These changes in cultured smooth muscle cells reflected the increased immunostaining for fibronectin and IL-113 observed in vivo in intact vessels (28), but we were able for the first time, through the in vitro studies, to establish a cause and effect relationship. These changes were rather specific in that the smooth muscle cells derived from host and donor coronary arteries were similar in phenotype, growth pattern, and protein synthesis. Although we cannot exclude that IL-113 may have affected expression of other molecules, by further showing that GAG synthesis from host and donor coronary artery smooth muscle cells were similar, it seemed that the increase in fibronectin did not reflect an increase in other extracellular matrix components that have previously been shown to be induced by IL-13 ( 18) .
In our in vivo studies, (28), we could not relate the intensity of immunostaining for fibronectin to the duration after cardiac transplant in the presence and absence of CsA therapy, which differs from our observations in vitro, in which a correlation was apparent. This may reflect the fact that in vivo there is initial paracrine stimulation of fibronectin synthesis, likely by IL-1 fl, which switches to an autocrine mechanism with increasing duration after the transplant, a process which may be accelerated in non-CsA-treated piglets. The paracrine source of IL-1,B may be the endothelial cells or the inflammatory cells. In fact, there appears to be intense immunostaining for IL-13 in the endothelium ofthe donor coronary arteries and our in vitro studies have confirmed increased synthesis of IL-# in cultured donor compared to host endothelial cells (42) . This explanation would be in keeping with previous reports in the literature suggesting that IL-I upregulates itself (43). If the switch to an autocrine mechanism of IL-113-induced increased smooth muscle fibronectin is accelerated in the absence of cyclosporine, but requires a certain duration of expression to be maintained in vitro, this would explain why the donor smooth muscle cell cultures that were harvested at later time points in both treated and untreated animals were those that showed the consistent increase in fibronectin synthesis.
The increase in donor fibronectin synthesis was associated with increased steady-state mRNA levels for fibronectin. This feature differs from our studies in the ductus arteriosus where mRNA did not correlate with protein levels and a post-transcriptional mechanism appears to account for the increase in fibronectin synthesis (23) . The difference may reflect the fact that the increase in ductus arteriosus fibronectin synthesis is related to a developmentally regulated program associated with morphogenesis, whereas the increase in the donor coronary artery is cytokine-mediated.
In our previous in vivo studies in piglets after heterotopic cardiac transplant experimental model, we described an increased number ofinflammatory cells adherent to the endotheHum and infiltrating the subendothelium as early features associated with the post-cardiac transplant coronary arteriopathy (28) similar to those observed in human tissue (4) . The increased fibronectin produced by smooth muscle cells may be chemotactic (44) and may serve to promote migration of inflammatory cells into the subendothelial space. Inasmuch as T cells express VLA-4 and VLA-5 fibronectin binding sites (10, 11, [45] [46] [47] , fibronectin may also be involved in lymphocyte positioning and "trapping" in the subendothelial space, which could lead to perpetuation of the inflammatory reaction (48) . Fibronectin can also participate in the activation and proliferation of these cells (9, 10, 49) associated with the release of cytokines and growth factors.
In addition, increased fibronectin production is associated with vascular smooth muscle cell migration into the subendothelium. An association between an increase in fibronectin (5), particularly the EIII A' isoform (6) which is expressed by migrating cells (50), and atherogenesis was previously reported. Moreover, in our earlier studies, we were able to show using three-dimensional collagen gels (51 ) and, more recently, using elastic membranes (52) that the increase in ductus arteriosus smooth muscle cell fibronectin synthesis is related to the cells' increased ability to migrate. This feature is related to the formation in vivo of intimal cushions, which partially narrow the lumen and assure that the vessel will close completely when it constricts in the postnatal period. Whereas others have also related fibronectin (53) or IL-1 (54) to proliferation ofsmooth muscle cells, we could not demonstrate this effect in our studies since we did not find differences in growth rate between host and donor cells.
Although we demonstrated increased immunostaining for IL-I,3 in the donor coronary artery tissue in the piglets (28) , other cytokines can also mediate increased fibronectin synthesis, e.g., TGF-f3, IL-1 a, and IL-6 (21, 24) . TGF-(3 is known to stimulate synthesis of extracellular matrix during inflammatory reactions (22) , and increased expression of IL-6, IL-la, and IL-1(3 has been described in cardiac allografts ( 13 ) . Moreover, Navab et al., in a co-culture system of smooth muscle cells, monocytes, and endothelial cells, demonstrated a decrease in fibronectin synthesis using both IL-1 and also IL-6 neutralizing antibodies (24) . We therefore used neutralizing antibodies to TGF-f3, IL-1 a, IL-6, and IL-1( to screen for inhibition of fibronectin synthesis in the donor compared to host coronary artery smooth muscle cells and found that only IL-1(3 consistently and selectively reduced fibronectin synthesis in donor coronary artery smooth muscle cells. To further support the specificity ofthe effect observed with the IL-I( neutralizing antibody, we demonstrated a similar consistent reduction in donor coronary artery smooth muscle cell fibronectin synthesis with the IL-1 ra. We also established that both the IL-13 antibody and IL-1 ra effects on fibronectin synthesis were not part of a nonspecific downregulation of protein synthesis.
In that the increase in donor compared to host fibronectin synthesis is associated with an increase in mRNA levels for fibronectin, it is not surprising that the reduction in donor fibronectin synthesis with the IL-1( antiserum is associated with a decrease in mRNA levels for fibronectin. Further studies could be directed to explore whether this reflects differences in fibronectin mRNA stability or transcription.
The IL-1 (-mediated increase in fibronectin synthesis was associated with increased production of this cytokine by smooth muscle cells, thus providing further evidence for an autocrine mechanism. Since we also showed that exogenous IL-13 could stimulate smooth muscle cell fibronectin synthesis, we cannot exclude the possibility that initially in vivo, the stimulation is paracrine, the source being endothelial or inflammatory cell followed by an autocrine upregulation (43). We propose that this mechanism is responsible for the sustained increase in fibronectin synthesis and maintenance of this phenotypic characteristic in vitro.
Because the IL-l ra has been effectively used therapeutically in the prevention of septic shock ( 55 ), and in the reduction of the inflammatory process in acute arthritis and colitis (56) , this reagent could be used in vivo in experimental animals to establish more definitively whether the IL-l(3-mediated increase in fibronectin synthesis is critical to the pathogenesis of the post-cardiac transplant coronary arteriopathy. It would also be interesting to direct future studies toward the isolation of a responsive element for IL-1( in the fibronectin promoter. This may allow more selective therapeutic targeting of this effect without interfering with the other functions of IL-1,B.
